Steven Schultz from Momentum (https://youtu.be/0bN3VrkgNFs) chose Sino BioPharm as his stock pick of the day.

“My stock pick this evening is China’s answer to Johnson & Johnson and perhaps Pfizer,  it’s a company called Sino BioPharm, it is a beneficiary of Covid in the review mirror but perhaps more importantly for viewers, the next 12 months they are looking to put online 33 new blockbuster drugs.”..

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.